Skip navigation

Managing Health Insurance Cost and Innovative Care

January 28-29, 2020
  • Miami, FL

CBI’s Specialty Therapies and Biosimilars Congress tackles the challenges involved in managing the cost and quality of innovative therapies that are controlling or conquering diseases that were once considered untreatable. Pharmaceutical executives, payers, PBMs, and specialty pharmacies gather for an open exchange of ideas on the latest challenges and trends. The conference includes a full track of programming on biosimilars in addition to one on specialty therapies. You choose from sessions in both tracks.

The biosimilars track explores the ever-expanding FDA pipeline of approved biosimilars and offers critical strategies to comply with evolving regulations, mitigate risk and execute long-term decisions to prepare for success. Some topics include the biosimilars pipeline, anticipated barriers to access with accompanying strategies for improvement and the latest FDA biosimilar guidance.

With a range of topics that includes reimbursement for rare disease therapies, adapting value-based design for specialty therapies, interfacing between ICER and pharmaceutical manufacturers and the effects on formulary decision making, comparing drug channels for therapies and paying for high-tech therapies, you won’t want to miss it!

Previous Attendees Acclaim:

Very good, well rounded and informative conference.

Regional Account Manager, UCB, Inc.

This conference has a great line-up of speakers and the conference atmosphere enabled excellent discussion.

Global Head, Pricing, Market Access, & Policy, Biosimilars, Merck

’Rookie' or ‘Veteran’ in the biosimilars space – this conference allows you to gain some key learnings! It’s the great intimate professional setting to learn from esteemed colleagues,
including potential competitors without risk!

Marketing, Merck

Provides an excellent overview of current payer mechanisms that interact with all players in healthcare space.

Regional Sales Executive, Reliance Rx Specialty Pharmacy

Specialty Therapies and Biosimilars Congress

Managing Health Insurance Cost and Innovative Care

CBI’s Specialty Therapies and Biosimilars Congress tackles the challenges involved in managing the cost and quality of innovative therapies that are controlling or conquering diseases that were once considered untreatable. Pharmaceutical executives, payers, PBMs, and specialty pharmacies gather for an open exchange of ideas on the latest challenges and trends. The conference includes a full track of programming on biosimilars in addition to one on specialty therapies. You choose from sessions in both tracks.

The biosimilars track explores the ever-expanding FDA pipeline of approved biosimilars and offers critical strategies to comply with evolving regulations, mitigate risk and execute long-term decisions to prepare for success. Some topics include the biosimilars pipeline, anticipated barriers to access with accompanying strategies for improvement and the latest FDA biosimilar guidance.

With a range of topics that includes reimbursement for rare disease therapies, adapting value-based design for specialty therapies, interfacing between ICER and pharmaceutical manufacturers and the effects on formulary decision making, comparing drug channels for therapies and paying for high-tech therapies, you won’t want to miss it!

Previous Attendees Acclaim:

Very good, well rounded and informative conference.

Regional Account Manager, UCB, Inc.

This conference has a great line-up of speakers and the conference atmosphere enabled excellent discussion.

Global Head, Pricing, Market Access, & Policy, Biosimilars, Merck

’Rookie' or ‘Veteran’ in the biosimilars space – this conference allows you to gain some key learnings! It’s the great intimate professional setting to learn from esteemed colleagues,
including potential competitors without risk!

Marketing, Merck

Provides an excellent overview of current payer mechanisms that interact with all players in healthcare space.

Regional Sales Executive, Reliance Rx Specialty Pharmacy